A. Sanchez-Salinas

An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion

J. Monserrat, M. Blanquer, C. Insausti, 2012, Transfusion.

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.

M. Juan, B. Paiva, J. Pérez-Simón, 2023, The Lancet. Oncology.

SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination

M. Tormo, M. Terol, C. Solano, 2023, Bone Marrow Transplantation.

One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

C. Solano, D. Navarro, R. Martino, 2023, Blood Cancer Journal.

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders

M. Tormo, C. Solano, D. Navarro, 2022, Journal of Hematology & Oncology.

SARS‐CoV‐2‐reactive antibody detection after SARS‐CoV‐2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group

C. Solano, D. Navarro, R. Martino, 2021, American journal of hematology.